Ardelyx Investigative Site 427

Meridian, Idaho 83642

Use our guide to learn which trials are right for you!

We've found
1 trials
at this facility
Hyperphosphatemia Clinical Trial
An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)
Status: Enrolling, Phase II
Updated: 4/7/2016
mi
from
Meridian, ID
Click here to add this to my saved trials